ClinConnect ClinConnect Logo
Search / Trial NCT06744491

Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum

Launched by UNIVERSITY OF TORONTO · Dec 16, 2024

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

Anabolic Sensitivity Aging Growth And Development Physical Activity Skeletal Muscle Stable Isotopes

ClinConnect Summary

This clinical trial is looking to understand how our bodies respond to a liquid protein meal at different ages, for both men and women, and based on how active we are. The study aims to find out how well our bodies can use protein for building and repairing muscles, a process known as anabolic sensitivity. This information could help us learn more about healthy aging and how physical activity affects our metabolism over time.

To participate, you need to be healthy and fall within certain age ranges: either between 8 to 16 years, or 18 to 35 years, or 60 to 80 years. Participants should also have a body mass index (BMI) that is considered normal to overweight. However, there are some restrictions; for example, if you regularly use certain medications, have specific health issues, or are pregnant, you may not be eligible. If you join the study, you can expect to consume a protein drink and provide information about your diet and physical activity. This research could provide valuable insights into how different factors influence our body's ability to process protein throughout our lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone)
  • Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
  • Chronological age between 8 to 16 years, with maturity offset \< -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
  • BMI between normal to overweight (18.5 - 29.9 kg/m2)
  • Exclusion Criteria:
  • Regular use of nonsteroidal anti-inflammatory dugs (with the exception of daily low-dose aspirin)
  • use of anticoagulants
  • use of a walker, cane, or assistive walking device
  • infectious or gastrointestinal disease
  • inability to comply with study protocol (e.g., unable to track diet)
  • regular tobacco use
  • self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
  • diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
  • pregnant
  • hormonal replacement therapy

About University Of Toronto

The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.

Locations

Toronto, Ontario, Canada

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported